Year: 2021

Jupiter, FL, Dec. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Marizyme Inc. (MRZM), a biotechnology company engaged in the development and commercialization of advanced healthcare products to prevent, treat and diagnose diseases of unmet clinical need, announced today that it has received notice of allowance for foundational patent applications for two of its core technologies in several key markets further strengthening the company’s intellectual property. Marizyme also announced today that it has retained the services of Dentons US LLP, the world’s largest law firm with more than 600 international patent lawyers and professionals in more than 80 countries, to manage its global patent portfolio.  Patent applications covering the company’s flagship commercial product, DuraGraft®,have been allowed in Brazil, China and Malaysia....

Company announcement no. 28 – 213 December 2021 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in NTG’s shares NTG Nordic Transport Group A/S CVR no. 12546106 (“NTG”) hereby announces in accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), to have received the following notification from persons discharging managerial responsibilities in NTG and persons closely associated with them in NTG’s shares and other financial instruments linked thereto: Karen-Marie Katholm (Board member)Karen-Marie Katholm has on 2 December 2021 purchased 1,000 shares in NTG of nominally DKK 20 each at a price of DKK 441.5 per share. Reference is made to the attached...

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that Psyence Chief Executive Officer, Neil Maresky, will be presenting at the virtual H.C. Wainwright 2nd Annual Psychedelics Conference on December 6th, 2021. For more information about the event and to register, visit https://hcwevents.com/psychedelics. To schedule a one-on-one meeting with Psyence management, please send an email to H.C. Wainwright at lk@hcwco.com, or IR@psyence.com. ABOUT PSYENCE GROUP: www.psyence.com Psyence is a public life science biotechnology company listed on the Canadian Securities Exchange and (CSE: PSYG) and quoted on the OTCQB (OTCQB: PSYGF), with...

SAN FRANCISCO, CA, Dec. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – APT Systems, Inc. (OTC Pink: APTY), a software development and fintech company, announced that it will move gold operations directly under APT which was further facilitated by the sale of its subsidiary, AUREX Trading and Recovery. This is part of an initiative to tighten corporate focus on its core business being its Verifundr escrow services and upcoming launch of its stablecoin, Spera. “We are streamlining to maximize our attention on the Verifundr platform and our Spera stablecoin,” says Glenda Dowie, Founder and Chief Executive Officer of APT Systems, Inc. “We are moving to a dedicated gold metal managing operation inside of APT, to maintain our commitment for partial physical gold backing of Spera.” APT Systems has agreed to sell AUREX Trading, its...

MCLEAN, Va., Dec. 03, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 10-year terms. The company expects to issue approximately $1.2 billion in K Certificates (K-135 Certificates), which are expected to settle on or about December 9, 2021. K-135 PricingClass Principal/Notional Amount (mm) Weighted Average Life (Years) Spread (bps) Coupon Yield Dollar PriceA-1 $117.610 6.77 S+17 1.60600% 1.59536% $99.9947A-2 $893.718 9.80 S+27 2.15400% 1.81122% $102.9941A-M $190.000 Sold via WI-K135X1 $1,011.328 9.21 T+110 0.19188% 2.54158% $1.6741XAM $190.000 9.63 T+105 0.36815% 2.49918% $3.3675X3 $63.227 9.71 T+280 2.68215% 4.25060% $21.4464*For...

VILNIAUS BALDAI AB plans to release financial results in Financial Year 2022 (starting September 1, 2021 and ending August 31, 2022) according to the following plan: – December 23, 2021 – consolidated interim financial statements for the three months; – April 01, 2022 – consolidated interim financial statements for the six months; consolidated interim report for the six months; – June 27, 2022 – consolidated interim financial statements for the nine months; – October 24, 2022 – consolidated interim financial statements for the twelve months; – November 25, 2022 – consolidated annual financial statements; consolidated annual report.Additional information:Chief Financial OfficerEdgaras KabečiusPhone No.: +370 (5) 2525700

MCLEAN, Va., Dec. 03, 2021 (GLOBE NEWSWIRE) — Appian (NASDAQ: APPN) announced today that Mark Lynch, Chief Financial Officer, Marc Wilson, Founder and Chief Partner Officer, and Sri Anantha, Director of Investor Relations, will be presenting and hosting meetings with investors at the Barclays Global Technology, Media, and Telecommunications Conference. The presentation is scheduled for Tuesday, December 7, 2021 at 8:35 a.m., Eastern Time. The presentation will be webcast live, and replays will be available for a limited time under the “News and Events ” section of the Company’s investor relations website at http://investors.appian.com. About Appian Appian helps organizations build apps and workflows rapidly, with a low-code platform. Combining people, technologies, and data in a single workflow, Appian can help...

AS LHV Group as the sole shareholder resolved to extend the mandates of subsidiary AS LHV Pank supervisory board members Madis Toomsalu and Heldur Meerits and subsidiary AS LHV Varahaldus supervisory board member Madis Toomsalu from the end of the current term until 31 March 2026.   Priit RumCommunication ManagerPhone: +372 502 0786Email: priit.rum@lhv.ee